Effect of baseline rheumatoid factor (RF) levels on DAS28-response to standard DMARD-combination treatment in patients with rheumatoid arthritis (RA)

Anand N. Malaviya, John B. Collings, Ashima Makol, Prashant Kaushik

Research output: Contribution to journalArticle

1 Scopus citations

Abstract

Objective: Rheumatoid factor (RF) positivity has been associated with an unfavourable outcome in rheumatoid arthritis (RA). Our study aimed to find a baseline RF cut-off level that would determine the response to standard disease modifying anti-rheumatic drug (DMARD) combination treatment. Patients and methods: We studied 233 seropositive (RF levels ≥20 IU/mL at presentation) RA patients over a period of up to 5 years. Disease activity was assessed at each patient-encounter using disease activity score on 28 joints (DAS28). Treatment consisted of weekly methotrexate, daily hydroxychloroquine and low dose oral methlyprednisolone as an adjunct. Sulfasalazine or leflunomide were added to the ongoing regimen if satisfactory response was not achieved by 3 months of treatment. Individual response of patients to treatment was graded using the following DAS28 cut-off values: <3 as low disease activity (satisfactory response), ≥3 as moderate and ≥5.1 as high (unsatisfactory response). Results: By analyzing all possible 2 x 2 contingency tables based on the different values of RF in the data set, using Fisher's exact test of association between RF levels and DAS28 values, a cut-off level for RF of 70 IU/mL gave the optimal discrimination between 'low' versus 'moderate or high' disease activity in the follow-up. Conclusion: A baseline RF cut-off value of 70 IU/mL appears to predict a 'satisfactory' versus 'unsatisfactory' response to standard DMARD-combination therapy in RA over time.

Original languageEnglish (US)
Pages (from-to)51-55
Number of pages5
JournalIndian Journal of Rheumatology
Volume4
Issue number2
DOIs
StatePublished - 2009
Externally publishedYes

Keywords

  • Disease-modifying anti-rheumatic drugs (DMARDS)
  • Drug response
  • Predictive value
  • Rheumatoid arthritis
  • Rheumatoid factor

ASJC Scopus subject areas

  • Rheumatology

Fingerprint Dive into the research topics of 'Effect of baseline rheumatoid factor (RF) levels on DAS28-response to standard DMARD-combination treatment in patients with rheumatoid arthritis (RA)'. Together they form a unique fingerprint.

  • Cite this